Microplastic levels in children with and without inflammatory bowel disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project collects intestinal tissue (during routine endoscopy), stool, urine, and blood from children under 18 who have IBD and from controls without IBD. Raman spectroscopy will be used to detect and characterize microplastics in each sample type. No medications or experimental interventions are given; samples are collected during clinical procedures already planned. Researchers will compare microplastic detection rates and burden between the IBD and control groups to see if differences exist.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \<18 years
* Undergoing clinically indicated gastrointestinal endoscopy
* For IBD group: confirmed diagnosis of Crohn's disease or ulcerative colitis
* For control group: no current or past diagnosis of IBD

Exclusion Criteria:

* Age 18 years or older
* Lack of informed consent from legal guardian
* Lack of written assent from the participant if age ≥13 years

Where it's running

• Medical University of Gdańsk, Department of Pediatrics, Gastroenterology, Allergolgy and Nutrition
  Gdansk, Poland Recruiting

Study contacts

• Study coordinator: Dominika Marszk, MD
• Email: dsierdzinska@gumed.edu.pl
• Phone: +48609619101

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Claudin-2 Immunostaining to Detect Active or Inactive Inflammation in IBD Biopsies

  This study tests whether staining for Claudin-2 in intestinal biopsy samples can help identify active vs. inactive inflammation in people with ulcerative colitis or Crohn's disease.

  Recruiting IRCCS Policlinico S. Donato · San Donato Milanese, Mi · NCT07710287

• Wearable data to spot IBD flareups in people with ulcerative colitis or Crohn's disease

  This study tests whether heart‑rate variability from participants’ own wearables can help predict IBD flares.

  Recruiting at 2 sites Maastricht University Medical Center · 's-Hertogenbosch and 2 other locations · NCT07647640

• DISC-0974-201 for adults with IBD-related anemia

  This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.

  Recruiting at 15 sites Phase 2 Disc Medicine, Inc · Birmingham, Alabama and 14 other locations · NCT07368972

• Gut bacteria and immune-cell energy in people with IBD and healthy adults

  We will test whether gut bacteria change how immune cells use energy in people with Crohn's disease or ulcerative colitis and in healthy adults by using a short antibiotic course and a labeled fiber.

  Recruiting Phase 2 Assistance Publique - Hôpitaux de Paris · Paris · NCT07300553

• Switching to guselkumab for adults with active IBD after ustekinumab

  We will try guselkumab (Tremfya) in adults with active IBD whose symptoms didn't improve enough on ustekinumab.

  Recruiting at 12 sites TIDHI Innovation Inc. · Calgary, Alberta and 13 other locations · NCT07245394

• Zymfentra (infliximab-dyyb) real-world cohort

  This project will see if Zymfentra (infliximab-dyyb) reduces symptoms over one year in adults with Crohn's disease, ulcerative colitis, or indeterminate colitis who are starting or switching to the drug as part of routine care.

  Recruiting at 11 sites University of North Carolina, Chapel Hill · New Haven, Connecticut and 10 other locations · NCT07237516

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.